Impact of antifungal treatment on Candida–Pseudomonas interaction: a preliminary retrospective case–control study

[1]  J. Garnacho-Montero,et al.  A bedside scoring system (“Candida score”) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization* , 2006, Critical care medicine.

[2]  T. Fabian,et al.  Candida sp. isolated from bronchoalveolar lavage: clinical significance in critically ill trauma patients , 2006, Intensive Care Medicine.

[3]  C. Cracco,et al.  Bonne pratique de la fibroscopie bronchique chez le patient ventilé , 2006 .

[4]  Sanjay Saint,et al.  Clinical and economic consequences of ventilator-associated pneumonia: A systematic review , 2005, Critical care medicine.

[5]  A. Prince,et al.  Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. , 2005, American journal of respiratory and critical care medicine.

[6]  R. Piarroux,et al.  Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients(*) , 2004, Critical care medicine.

[7]  R. Kolter,et al.  A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology , 2004, Molecular microbiology.

[8]  S. Kohno,et al.  Acute infection with influenza virus enhances susceptibility to fatal pneumonia following Streptococcus pneumoniae infection in mice with chronic pulmonary colonization with Pseudomonas aeruginosa , 2004, Clinical and experimental immunology.

[9]  J. Timsit,et al.  Practices in non-neutropenic ICU patients with Candida-positive airway specimens , 2004, Intensive Care Medicine.

[10]  C. Celum The interaction between herpes simplex virus and human immunodeficiency virus. , 2004, Herpes : the journal of the IHMF.

[11]  C. Marquette,et al.  Diagnosis of hospital-acquired pneumonia: postmortem studies. , 2003, Infectious disease clinics of North America.

[12]  D. Pittet,et al.  Management of candidiasis Management of Candida species infections in critically ill patients , 2003 .

[13]  R. Kolter,et al.  Pseudomonas-Candida Interactions: An Ecological Role for Virulence Factors , 2002, Science.

[14]  D. Maki,et al.  The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida , 2002, Annals of Internal Medicine.

[15]  C. Heyer,et al.  Biofilm formation in endotracheal tubes. Association between pneumonia and the persistence of pathogens. , 2002, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

[16]  Jean-Yves Fagon,et al.  Ventilator-associated pneumonia. , 2002, American journal of respiratory and critical care medicine.

[17]  David S. Jones,et al.  Implications of endotracheal tube biofilm for ventilator-associated pneumonia , 1999, Intensive Care Medicine.

[18]  E. Phizicky,et al.  A functional homolog of a yeast tRNA splicing enzyme is conserved in higher eukaryotes and in Escherichia coli. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[19]  E. Law,et al.  Increased susceptibility to lethal Candida infections in burned mice preinfected with Pseudomonas aeruginosa or pretreated with proteolytic enzymes , 1986, Infection and immunity.

[20]  J. Timsit,et al.  Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia. , 2006, Chest.

[21]  D. Pittet,et al.  Management of Candida species infections in critically ill patients. , 2003, The Lancet. Infectious diseases.